PPT-The challenges of using in-vitro tests for Vaccine
Author : tatiana-dople | Published Date : 2018-11-20
Matching 20152016 Abdelghani Abid BinTarif Bob J Statham Anna B Ludi Donald P King FMD Reference Laboratory The Pirbright Institute is the OIE FAO and
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "The challenges of using in-vitro tests f..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
The challenges of using in-vitro tests for Vaccine: Transcript
Matching 20152016 Abdelghani Abid BinTarif Bob J Statham Anna B Ludi Donald P King FMD Reference Laboratory The Pirbright Institute is the OIE FAO and EU Reference Laboratory for footandmouth disease FMD The Serum Assay Unit carries out vaccine matching tests for international samples received by the World Reference Laboratory WRL to characterise the antigenic relationship r. Through its innovative research programs the ompany identif ies new biomarkers for acute conditions and diseases and with clinical collaborators conduct rigorous clinical trials to validate the biomarkers for routine clinical use Astute 0HGLFDO575 bacterial pneumonia. . Lessons learned—and yet to be learned. William Hausdorff, PhD. Vaccine Development Leader, Pneumococcal Vaccines. GlaxoSmithKline . Biologicals, . Wavre. , Belgium. Pneumonia is the major manifestation of . 2013 Market Analysis. Historical Trends. 2013 Market Analysis. Historical Information. In Vitro, of . L. atin origin, literally means “in glass” due to the initial administration of drugs and biological specimens via a small glass tube. . 1. Scope. importance of vaccination in Health Care. issues. local . and global . challenges . solutions. 2. Vaccines 4. th. Edition. Vaccination has greatly reduced the burden of infectious . diseases. modelling. for public health decision-making. John Edmunds. , Jess Metcalf, Justin . Lessler. john.edmunds@lshtm.ac.uk. Why use models?. Observational studies of impact are retrospective, and difficult to interpret. In vitro. Testing be used for Toxicity Assessment instead of . in vivo. Approaches?. Timothy J. Shafer. 2012 SOT In vitro Lunch. Disclaimer: The views expressed . in this presentation . are solely those of the Author. They do not represent Agency . In vitro. Testing be used for Toxicity Assessment instead of . in vivo. Approaches?. Timothy J. Shafer. 2012 SOT In vitro Lunch. Disclaimer: The views expressed . in this presentation . are solely those of the Author. They do not represent Agency . What is In Vitro Fertilization. IVF is usually used in people with infertility, or with genetic problems. . Mature eggs must be collected as well as mature sperm. . The eggs are fertilized by the sperm in a lab, then they place a few fertilized eggs into a woman’s uterus. . Stata. Eduardo . Ortiz-Panozo. EUSMEX 2013. Evaluation of screening tests. Frequent in public health . Early stages of disease. Types:. Comparing results to a gold standard. Comparing results among tests. Dr Sitna Mwanzi. Medical Oncologist. Aga Khan University Hospital. 22. nd. April 2016. Objectives. Case presentation. Diagnostic challenges. Treatment challenges. Case Presentation. 35 year old female. 1 2 due to damage to the Fallopian tubes, obstructing a contact between the egg and the sperm (Fig. 1), whereas male infertility is linked to impaired sperm quantity and quality. Fig. 1. The fertiliza Medical treatment which helps infertile couples to have baby.. Used for the first time in United States in 1981.. More than 4 million babies have been born.. First test tube baby born in England on 25 july,1978 named Louise Brown. . Coverage. 2017 WHO/UNICEF . Estimates of National immunization Coverage . (Data as of July 2018). Global DTPcv3 Coverage and Number of Unvaccinated and Under-vaccinated Infants by WHO Region. DTP3 coverage remains at 85% in 2017, leaving 19.9 million children vulnerable to vaccine preventable diseases. Vaccine Procurement Workshop. Tbilisi, April, 2019. III. Vaccine Procurement in Practice. II. Vaccine Procurement Organogram. MoH. UNICEF SD. MoF. contractors. UNICEF CO. UNICEF procurement . State Procurement Agency.
Download Document
Here is the link to download the presentation.
"The challenges of using in-vitro tests for Vaccine"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents